Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

PFAS Exposure™, the First At-Home Blood Test to Detect and Measure 40+ PFAS Compounds, Now Available Nationally from empowerDX

PFAS, or "forever chemicals," in the body are linked to serious health issues and knowing exposure levels is key to monitoring health effects


News provided by

empowerDX

Jan 21, 2022, 08:45 ET

Share this article

Share toX

Share this article

Share toX


FRAMINGHAM, Mass., Jan. 21, 2022 /PRNewswire-PRWeb/ -- PFAS Exposure™, the first at-home test to determine levels of PFAS in a person's blood and measure 47 of these PFAS "forever chemical" compounds, is now available from empowerDX, a leading online health and wellness resource for a wide variety of at-home health testing.

A press conference announcing complete details of empowerDX's new PFAS Exposure test will be held today, January 21 at 10:30 a.m. ET. Anyone may access at the Zoom link below or view the conference later posted in the company's newsroom.

“With the ease of our at-home finger prick test, we have enabled access to information on the amount of PFAS chemicals lurking in our bodies, thus allowing a level of insight regarding an environmental health determinant that transcends genetics, lifestyle and socioeconomics." Dr. Travis Wilkes, MD

Post this

Per- and Polyfluoroalkyl Substances (PFAS), such as PFOA, PFOS, and GenX, are man-made substances that have been used in industry and consumer products worldwide since the 1950s Elevated levels of PFAS are linked to cancer, thyroid disease, immune suppression, elevated cholesterol, respiratory disease, and decreased fertility. One report by the Centers for Disease Control and Prevention's (CDC) National Health and Nutrition Examination Survey (NHANES) found PFAS in the blood of 97% of Americans.

The new, self-collected sampling kit by empowerDX measures the presence and levels of more than 40 PFAS compounds in capillary whole blood, significantly more than any other test currently available. The PFAS Exposure blood test expands upon the CDC National Health and Nutrition Examination Survey (NHANES) biobank database where 16 PFAS compounds in serum are reported.

"Prior to the launch of our PFAS Exposure blood test, it was very difficult to understand an individual's unique exposure to these forever chemicals in order to factor it into personalized risk assessment, screening and diagnostic planning," said Dr. Travis Wilkes, M.D., Medical Director of empowerDX. "With the ease of our at-home finger prick test, we have enabled access to information on the amount of PFAS chemicals lurking in our bodies, thus allowing a level of insight regarding an environmental health determinant that transcends genetics, lifestyle and socioeconomics."

Knowing the levels of PFAS in blood can help a person monitor environmental impacts to their own health. PFAS chemicals are used to make water-, grease- and stain-repellent coatings, and are found in such common items as fast-food wrappers and microwave popcorn bags, stain resistant carpet and clothes, cosmetics, non-stick cookware, cleaning products, and more. PFAS can also be found in soil, air, drinking water, and ground water.

Other major sources of PFAS are firefighting products, foam used to battle fires (Aqueous Film Forming Foam – AFFF), and military applications. Many PFAS "hot spots" are centered around military bases, and first responders in firehouses nationwide are at greatly elevated risk.

The new test requires no prescription, which is a leap forward for improving accessibility to testing in impacted communities. This test can be used for ages six months and up, and comes with complete instructions for a simple, at-home, finger prick blood collection, as well as return packaging direct to the laboratory. Results are provided securely and digitally within 10 days from receipt of sample, and include a complete list of the level of each type of PFAS detected. A detailed Test Guide is included with every lab report to help persons better understand their results; all empowerDX Test Guides are physician-reviewed and based on peer-reviewed research or emerging evidence.

If a person's test shows elevated levels, they can reduce their exposure to PFAS with diet changes – for example by drinking water tested as PFAS-free, avoiding fish caught in high-risk areas, not cooking with nonstick pans, and avoiding water-repellant food packaging. Consult the Consumer Product Safety Commission at (800) 638-2772 for exact products containing PFAS or view the tip sheet from the Environmental Working Group (EWG).

Other valuable resources include referring to the EWG's high risk area map. People in hot spots should exercise caution with water and soil exposure. There are CDC studies in seven areas of the U.S. that expand upon landmark work that began with the Portsmouth, N.H. Pease Study.

PFAS Exposure blood tests from empowerDX can be purchased online for $399 and are shipped directly to the customer. Contact empowerDX at [email protected] or via the online help portal.

Reporters may use the chat room to ask questions of the presenters at today's 10:30 a.m. ET Zoom press conference by registering at the following link:
https://zoom.us/webinar/register/WN_Zg1344LuQmG6mxy4ZFMEUg

About empowerDX
empowerDX is the online shop for easy at-home health testing. empowerDX specializes in FDA-authorized COVID-19 testing, women's health, men's health, sexual health and general wellness testing. empowerDX is positioned to lead the market for cutting edge, self-collected diagnostic and non-diagnostic testing at several U.S.-based CLIA-certified clinical and environmental labs which meet rigorous FDA and CDC standards. Delia Vallejo is vice president and general manager; Dr. Travis Wilkes, MD is medical director. To learn more, visit empowerdxlab.com

Media Contact

Becky Peterson, empowerDX, 770.367.0321, [email protected]

SOURCE empowerDX

Modal title

PFAS lancet blood collection on fingertip.
PFAS lancet blood collection on fingertip.
PFAS lancet blood collection on fingertip.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.